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ABSTRACT Several heterogeneities in the baboon endoge-
nous virus (BaEV) genomes that are present in the DNA of normal
baboon tissues and the baboon cell strain BEF-3 have been de-
scribed previously. To study these genomes, we cloned BaEV pro-
viruses from BEF-3 cellular DNA into the A vector Charon 4A.
Of the four full-length clones isolated, one was nondefective as
determined by transfection. The sequence ofa portion ofthis clone
was found to code for amino acids 61-91 in the p30 region of the
gag gene. This identification allowed us to align the restriction map
with the BaEV genetic map. One heterogeneity, a BamHI site 2.4
kilobases (kb) from the proviral 5' end, was located close to the
gag-pol junction; another, a BamHI site 1.4 kb from the 5' end of
the genome, corresponded to the gag p30 coding sequence for
amino acids 32-34; and a third, a Xho I site, was near the 3' end
of the pol gene. To select the nondefective BaEV genomes from
BEF-3 cells, we infected permissive cells with virus produced by
BEF-3 cells and also transfected BEF-3 cellular DNA into per-
missive cells. The BaEV genomes in the permissive recipient cul-
tures were then analyzed by restriction enzyme analysis. These
nondefective genomes were found to be heterogeneous with re-
spect to the gag-pol BamHI site and the Xho I site, but all were
found to contain the BamHI site 1.4 kb from the 5' end of the
genome.
Baboon cellular DNA contains numerous copies of the baboon
endogenous virus (BaEV) genome. Although these sequences
are not normally expressed at detectable levels in baboon cells,
the cells do reproducibly release infectious BaEV under certain
conditions. Thus, it appears that at least some of the viral ge-
nomes in baboon cells are complete nondefective proviruses.
In a previous study we analyzed the BaEV genomes in the
baboon cell strain BEF-3 by restriction mapping (1). This cell
strain is unusual in that it produces high levels of BaEV, it con-
tains even more BaEV genomes per diploid equivalent ofDNA
than does normal baboon tissue, and, unlike baboon tissue
DNA, its cellular DNA gives rise to BaEV upon transfection of
permissive cells. In our previous studies we found a consider-
able degree of sequence heterogeneity among the BaEV ge-
nomes in BEF-3 cellular DNA.
As one approach to understanding the significance of these
polymorphisms in the BaEV genomes, we have evaluated the
infectivity ofa number ofdifferent genomes isolated from BEF-
3 cells. Several strategies were used in the isolation ofindividual
nondefective genomes, including recombinant DNA methods
as well as more classical virological techniques. Each isolated
genome was characterized by restriction mapping; in addition,
the restriction map of one proviral clone was aligned with the
BaEV genetic map by DNA sequence analysis of recombinant
bacteriophage DNAs containing BaEV genomes. The results of
these studies show that: (i) only a subset of the BaEV genomes
in BEF-3 cells are nondefective; (ii) there is sequence hetero-
geneity even within this subset; and (iii) different genomes
within this subset differ with respect to the rate of virus rep-
lication after transfection of permissive cells.
MATERIALS AND METHODS
Virus Isolation. Filtered supernatant from BEF-3 cells, a
baboon embryo fibroblast cell strain that releases BaEV (2), was
diluted serially 1:10. We applied 1 ml ofeach dilution to at least
15 cultures of a human RD cell clone (3). The RD cells were
grown in Eagle's minimal essential medium with 10% fetal calf
serum. After 4 weeks, the cultures were tested for the presence
of retrovirus by reverse transcriptase assay. An end-point di-
lution was defined as the highest dilution at which at least one
culture was producing virus. DNA was isolated, as described
(1), from all reverse transcriptase-positive cultures.
Transfection. The D17 line of dog cells (4) was grown in
Dulbecco's modified Eagle's medium with 10% fetal calfserum.
Sixty-millimeter dishes were seeded with 8 X 105 D17 cells.
The following day the cells were exposed to a calcium phos-
phate-DNA precipitate for 4 hr in growth medium (5) and then
treated with 15% glycerol in 0.13 M NaCl/5 mM KCV/20 mM
D-glucose/20 mM Hepes, pH 6.9/0.35 mM Na2HPO4 (HBS)
for 2 min. Transfections were performed with 15 ,ug of cellular
DNA or with 1 ,ug of clone DNA plus 15 ,g of uninfected dog
cell (carrier) DNA. Each experiment included a rmock-trans-
fected control which was treated with carrier DNA alone; these
control cultures were uniformly negative in all virus assays.
Transfected cells were passaged in growth medium with Po-
lybrene (2 ,ug/ml) for up to 8 weeks. They were screened for
BaEV production by in situ hybridization of the monolayers
with BaEV [32P]cDNA (details to be published elsewhere). All
cultures that were positive in this rapid assay ultimately became
positive in reverse transcriptase assays as well. The cultures
were also tested for BaEV p30 by competition radioimmunoas-
say (courtesy of C. V. Benton, Frederick Cancer Research Cen-
ter). The cells that had been exposed to BEF-3 DNA or clone
14A2 DNA were found to contain 2.5-5.3 ,ug of BaEV p30 pro-
tein per mg of cell protein; the mock-transfected cultures con-
tained less than 0.03 ,ug/mg.
Molecular Cloning, Restriction Mapping, and DNA Se-
quence Analysis. BEF-3 cell DNA was partially digested with
Abbreviations: BaEV, baboon endogenous virus; kb, kilobase(s); bp,
base pair; R-MuLV, Rauscher murine leukemia virus.
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EcoRI (New England BioLabs) for 5, 10, 15, or 20 min at 0.1
enzyme unit/,ug of DNA. The digests were pooled and centri-
fuged in sucrose gradients. DNA 15-25 kb long was selected
and ligated into the EcoRI arms of Charon 4A A DNA (6). This
DNA was then packaged in vitro into infectious A phage (7, 8)
to yield a library of BEF-3 cell DNA fragments containing 1.9
X 105 infectious particles (9). After amplification of the library
by plate lysis growth in E. coli Dp 50 sup F, we screened
1.5 x 10 plaques by filter hybridization (10) with a BaEV
[32P]cDNA probe (11). The recombinant clone DNAs and high
molecular weight cellular DNAs were mapped by restriction
enzyme analysis in Southern blotting experiments as described
(1, 11). We utilized the technique of Maxam and Gilbert (12)
for DNA sequence analysis of purified recombinant DNA re-
striction fragments.
RESULTS
We previously reported (11) the physical map of the BaEV ge-
nome derived by restriction analysis of BaEV unintegrated lin-
ear DNA. We showed that the restriction map of the integrated
BaEV genomes of BEF-3 cells and baboon tissues is consistent
with the unintegrated DNA map but that the integrated ge-
nomes are heterogeneous with respect to several DNA se-
quence features summarized in Fig. 1 (1). These include BamHI
cleavage sites (ZA) and (BC). The presence of a previously de-
scribed 150-base-pair (bp) insert in BamHI fragment B (1) has
been clarified; instead of an insert, some proviruses contain a
previously undetected BamHI site, termed (AB*), located
about 150 bp from BamHI site (AB) (unpublished data). The
map also shows the presence of a heterogeneous Xho I cleavage
site 5.5 kb from the 5' end of the genome (data shown below).
Cloning of Cellular Proviral DNA. Because BaEV uninte-
grated linear DNA and the BaEV proviruses in BEF-3 cells
contain a single EcoRI cleavage site, we chose to clone the in-
tegrated BaEV proviruses by incomplete EcoRI cleavage of the
BEF-3 cellular DNA, ligation into Charon 4A A DNA, and in
vitro packaging. Our initial screening of the BEF-3 cell recom-
binant DNA library yielded 20 positive clones. Four of these
contained full-length BaEV genome inserts. In these four
clones, the lengths of the EcoRI inserts were determined by
electrophoresis of the fragments released by digestion with
EcoRI. The restriction maps of these four clones are summa-
rized in Fig. 2.
The genomes of clones 7B2 and 2A1 lack the BamHI site
(AB*) [genomes of this class were previously described (1) as
containing a 150-bp insert]. Clones 14A2 and 15A1, on the other
hand, contain the BamHI site (AB*) (Figs. 1 and 2) and, in this
regard, they are similar to the majority ofother BaEV proviruses
in BEF-3 cellular DNA.
Aligning the Genetic Map with the Restriction Map. In order
to localize the BaEV heterogeneities in the genetic map, we
began to determine DNA sequences of pertinent regions of the
BaEV provirus genome. Clone 14A2 DNA was cleaved with
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FIG. 1. Restriction map of BaEV genomes in BEF-3 cell DNA.
Solid lines, invariant restriction sites in these BaEV genomes; broken
lines, observed heterogeneities.
BamHI and the 3.75-kb fragment B + C (Fig. 1) was isolated
from an agarose gel after electrophoresis (13). The BamHI ends
were labeled with [a-32P]nucleotides by using the Klenow frag-
ment of DNA polymerase (13). After recleavage with Pst I and
electrophoretic isolation of the 1.0-kb BamHI/Pst I fragment,
we determined the sequence of a 92-nucleotide-long portion of
the fragment by the procedure of Maxam and Gilbert (12) (Fig.
3). As shown below, this region begins 84 nucleotides to the
right of BamHI site (AB*) and lies in the gag p30 gene. The
sequence of the BaEV p30 protein has been determined only
through amino acid 36 (14) but that of Rauscher murine leu-
kemia virus (R-MuLV) has been completely determined (ref.
15; L. E. Henderson, T. D. Copeland, and S. Oroszlan, per-
sonal communication). When the 92-nucleotide-long BaEV
DNA sequence was translated, one reading frame was found to
correspond to a run of 29 of 30 identities with the R-MuLV p30
protein, amino acids 61-91. Based on this homology with R-
MuLV, we conclude that this sequence is located within the
BaEV p30 encoding region.
Having oriented the BaEV BamHI fragment within the gag
p30 protein, we wanted to determine to which amino acid res-
idues BamHI site (AB*) corresponded. Two results allowed us
to do so. First, DNA sequence analysis of an AKR-MuLV re-
combinant DNA clone (unpublished data) showed that the DNA
sequence immediately following a BamHI site codes for a se-
quence in the gag p30 gene beginning at R-MuLV amino acid
35 (Fig. 3). As shown, the region from amino acids 35-72 con-
tains 34 of 38 identities with that of R-MuLV. Furthermore, the
AKR-MuLV DNA sequence coding for amino acids 61-72 (a run
of 35 nucleotides) is completely identical to the BaEV DNA
sequence in this region. Thus, the BaEV genome is homologous
not only to R-MuLV but also to AKR-MuLV in the gag p30
gene. Second, upstream from the sequenced 92 bp of BaEV
DNA, we searched for a R-MuLV amino acid sequence corre-
sponding to one translated reading frame of a BamHI recog-
nition site, 5' G-G-A-T-C-C 3'. It is not known whether R-
MuLV contains a BamHI site in this region but, because amino
acid sequence data were available for R-MuLV but not for the
closely related AKR-MuLV which does contain a BamHI site
in this region (see above), we considered the possibility that the
amino acid sequence encoded by the BamHI site is conserved
in R-MuLV. Only one such potential BamHI site was located,
sequence Glu-Asp-Pro at positions 32-34 in the gag p30 pro-
tein, and could be encoded by codons GAA/GAG-GAC/GAT-
CCN. In the homologous region of the BaEV p30 protein, the
amino acid sequence was reported to be Gln-Asp-(Gln) which
could be coded by CAA/CAG-GAC/GAT-CAA/CAG (14).
However, the third residue, Gln, was only tentatively assigned
because proline was also detected in that cleavage step (ref. 14;
Fig. 1).
Thus, we conclude that BamHI site (AB*) is part ofthe coding
sequence for the p30 amino acids 32-34, Gln-Asp-Pro, and is
located 84 bp to the left of the BaEV fragment that codes for
amino acids 61-91. The sequence coding for amino acids 32-34
would be located 96-102 bp from the 5' end of the p30 part of
the gag gene, assuming that there is no noncoding DNA in this
region. The gag-encoded proteins, p30 + plO, total approxi-
mately 316 amino acids and thus require 948 bp of the DNA
coding sequence. Thus, the plO gene would terminate =850
bp to the right of BamHI site (AB*) or 2.25 kb from the 5' end
of the genome. Because BamHI fragment B is ,1.0 kb long,
this places the heterogeneous BamHI site (BC) 150 bp to the
right of the end of the gag gene.
Infectivity. To determine whether any ofthe four full-length
recombinant clones was nondefective, we assayed their ability
to effect the spread of BaEV upon transfection of permissive
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FIG. 2. Restriction maps of four full-length BaEV genomes isolated from the BEF-3 cellularDNA recombinant X library, showingBaEV genome
and baboon flanking DNA restriction sites. H3, HindI; BI, BamHI; PI, Pvu I.
cells. In repeated tests, clone 14A2 DNA (like BEF-3 DNA) was
always positive; clones 7B2, 2A1, and 15A1 were always neg-
ative. Cultures transfected with clone 14A2 DNA, however,
were reproducibly slower in becoming fully virus-positive than
were cultures transfected with BEF-3 DNA, even though the
number ofgenome equivalents of 14A2 DNA used were greater
than those of BEF-3 DNA (see below).
Characterization of Infectious Proviruses. Although the
DNA of clone 14A2 was infectious, it differed from the unin-
tegrated linear DNA obtained from three independent stocks
ofBaEV (1, 11) in that it lacked the BamHI cleavage site at (BC).
It seemed important to determine whether these differences
represented actual genetic differences or reflected some other
difference between the two sources of DNA. For example, it
30 40
seemed possible that genomes lacking the BamHI site rapidly
regenerate this site during viral growth in eukaryotic cells or
that a DNA modification could obscure this site in DNA isolated
from 14A2 bacteriophage particles. To test these possibilities,
we transfected clone 14A2 DNA onto dog cells, allowed the
progeny BaEV to spread through the dog cell culture, and then
examined the integrated BaEV genomes in this culture for the
presence of the BamHI site. The proviral DNA in these cells
was a faithful replica of 14A2 DNA, lacking BamHI site (BC)
(Fig. 4, lanes B and E). The controls in lanes A and C were
BamHI digests of BEF-3 DNA and a baboon tissue DNA, S984
(1), respectively. Thus, the BaEV genome in clone 14A2 "breeds
true" upon virus passage in mammalian cells; furthermore, the
absence of the BamHI site is a stable genetic property by which
50 60
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xX Phe Ser Gin Asp Pro Ala3 Ary Gly Leu Thr Ala Leu Ile Glu Ser Asp Leu Thr Thr His Gln Pro Thr Trp Asp Asp Cys Gln Gln Leu Leu Gly
4
5 Bam site CGG GGG CTG ACT GCA TTG ATT GAA TCC GAC CTC ACC ACC CAC CAG CCC ACC TGG GAT GAT TGC CAG CAA TTA TTA GGG
61 70 80 90
1 Thr Leu Leu Thr Gly Giu Giu Lys Gin Arg Val Leu Leu Giu Ala Ary Lys Ala Val Arg Gly Giu Asp Gly Arg Pro Thr Gln Leu Pro Asn
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FIG. 3. Schematic representation of DNA sequence and amino acid sequence data from a portion of the gag p30 gene of BaEV, R-MuLV, and
AKR-MuLV. *, Tentative amino acid assignment (see text). 1, R-MuLV amino acid sequence; 2a, BaEV amino acid sequence; 2b, BaEV, amino acid
sequence derived from DNA sequence; 3, AKR amino acid sequence derived from DNA sequence; 4, BaEV DNA sequence; 5, AKR DNA sequence.
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FIG. 5. Differences in Xho I restriction sites among individual
isolates of BaEV. Lanes A and L, Xho I digest of BEF-3 cellular DNA;
B,Xho I digest ofDNA from a culture of D17 cells that had been trans-
fected with BEF-3 DNA; C, Xho I digest of clone 14A2 DNA; D-K,Xho
I digests ofDNA from eight cultures of RD cells that had been infected
with end-point dilutions of BEF-3 supernatant virus. Lanes A and B
are from a different agarose gel than lanes C-L.
FIG. 4. Hybridization of BaEV [32P]cDNA to the BamHI digests
of transfected cellular DNA. Lanes: A,BamHI digest of BEF-3 cellular
DNA; B, BamHI digest of DNA from a culture of D17 cells that had
been transfected with clone 14A2 DNA; C, BamHI digest of DNA from
a baboon tissue, S984 (1); D, BamHI digest of DNA from a culture of
D17 cells that had been transfected with BEF-3 DNA; E and F, longer
autoradiographic exposures of B and D, respectively.
it differs from other infectious BaEV genomes.
We also analyzed the infectious BaEV genomes in BEF-3
cells directly. Two separate experimental approaches to this
question were used: (i) analysis of genomes replicated after
transfection of BEF-3 DNA; and (ii) analysis of the genomes
derived from individual particles of infectious BaEV produced
by BEF-3 cells.
In the former, we determined whether the integrated BaEV
proviruses in dog cells (the result of BEF-3 cell DNA transfec-
tion and virus spread) contained BamHI site (BC) and the in-
ternal Xho I site (see below). When DNA from the dog cells that
had been exposed to BEF-3 DNA was digested with BamHI
(Fig. 4, lanes D and F), two classes offragments were observed:
(i) intense bands at 3.75 kb due to molecules that were not
cleaved at BamHI site (BC) and at 1.85 kb, the other internal
BamHI fragment; and (ii) faint bands at 2.75 and 1.0 kb due to
molecules that were cleaved at BamHI site (BC). Densitometric
tracings (not shown) of this autoradiogram indicated that the
2.75-kb-band intensity was about 0.12 of that expected for a
fragment of that length if it were present in equal molar pro-
portion to the 1.85-kb band. Thus, BEF-3 DNA does contain
two classes of infectious proviruses that differ in the presence
of BamHI site (BC).
Some of the BaEV genomes in BEF-3 DNA were cleaved by
Xho I to yield a 5.1- and a 3. 1-kb fragment (Fig. 5, lanes A and
L). Unlike the case with BamHI, no Xho I site heterogeneity
was seen in the integrated BaEV genomes after transfection of
BEF-3 DNA onto dog cells. All BaEV proviruses that were de-
tected lacked the Xho I site (Fig. 5, lane B).
The second experimental approach for studying the infec-
tious BaEV genomes in BEF-3 cell DNA was through analysis
of newly integrated proviruses in the DNA ofRD cell cultures
individually infected with single infectious BaEV particles.
DNA from 14 end-point-positive cultures was digested with
BamHI. The results paralleled those observed in dog cells after
transfection of BEF-3 DNA. DNA from 10 cultures revealed
integrated BaEV genomes lacking the BamHI site (BC), from
3 revealed genomes having the BamHI site, and from 1 (lane
B) revealed genomes ofboth types (Fig. 6). Also consistent with
the transfection results was our observation that 13 of 14 end-
point-culture DNAs revealed BaEV genomes lacking the in-
ternal Xho I restriction site (8 are shown in Fig. 5). One DNA
(Fig. 5, lane D) revealed not only the 8.2-kb Xho I fragment but,
after long autoradiographic exposure (not shown), also revealed
trace amounts of the 5.1- and 3.1-kb Xho I fragments as well.
We interpret this to mean that this culture (which is a different
culture from the one described above as having two BaEV ge-
nomes with different BamHI sites) was either infected with two
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FIG. 6. BamHI digests of DNA from 14 cultures of RD cells that
hadbeen infected with end-point dilutions of BEF-3 supernatant virus.
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virus particles that differed with respect to the internal Xho I
site or that a mutation at that site occurred during growth in
culture.
DISCUSSION
We have previously shown that the BaEV genomes in BEF-3
cells and baboon tissues are quite heterogeneous (1). The pres-
ent report extends this work and focuses on those viral genomes
in BEF-3 cells that are infectious. As a first step in character-
izing these heterogeneities, we prepared a library of BEF-3
DNA fragments cloned into the A vector Charon 4A and isolated
several recombinant DNA clones containing full-length BaEV
proviral inserts. One of the full-length clones, clone 14A2, was
found to be infectious for dog cells.
We next attempted to localize the observed provirus heter-
ogeneities in the BaEV genetic map. By sequencing 92 nu-
cleotides in the DNA of clone 14A2, we were able to align the
DNA restriction map precisely with a known protein sequence
in the gag p30 gene (Fig. 3). Thus, we mapped one ofthe earlier
reported BEF-3 provirus heterogeneities, BamHI site (BC). If
there is no noncoding DNA in the gag gene or between the gag
plO and the polymerase genes, BamHI site (BC) is located in
the polymerase gene near its 5' end. Furthermore, BamHI site
(AB*)-was found to be part of the gag p30 coding sequence for
-amino acids 32-34. Recent unpublished DNA sequence data
in the env gene region allowed placement of the internal Xho
I site within the 3' end of the pol gene.
As we have shown, only a subset of the BaEV proviruses in
BEF-3 cells have any detectable infectivity. In particular, two
classes of BEF-3 proviruses are conspicuously absent in the in-
fectious provirus population isolated by either recombinant or
virological techniques: (i) genomes lacking BamHI site (AB*);
and (ii) those containing BamHI site [termed (ZA)] near the 5'
proviral end.
The nondefective genomes of BEF-3 cells are, themselves,
heterogeneous. The single infectious clone that we isolated
(clone 14A2) does not have BamHI site (BC) in its genome but
does contain the internal Xho I site. On the other hand, the
proviruses detected in permissive cell DNA after infection of
individual BaEV particles or transfection of BEF-3 cellular
DNA may or may not contain BamHI site (BC) but for the most
part do not contain the Xho I site.
The nondefective BaEV proviruses are heterogeneous in
their ability to replicate in permissive cells. When tested for
infectivity, cultures transfected with clone 14A2 DNA were re-
producibly slower in becoming fully virus-positive than were
cultures transfected with BEF-3 DNA. That is, 1 ,ug of clone
14A2 DNA containing ='195 ng ofBaEV proviral DNA resulted
in slower infection than did 15 ,ug ofBEF-3 cell DNA containing
-3 ng of BaEV proviral DNA, which consists of 100 proviral
genomes. Even if BEF-3 cellular DNA contains 10 infectious
proviruses per diploid equivalent, more than 650 times as much
clone 14A2 proviral DNA as BaEV sequences in these BEF-3
proviruses resulted in a weaker transfection after 3 weeks in
culture. This result, together with the fact that no infectious
proviruses containing the internal Xho I site were detected in
permissive cell DNA after transfection with BEF-3 DNA or in-
fection with individual BaEV particles [except for traces in one
end-point culture (Fig. 5)] indicates that the Xho I site-con-
taining proviruses in BEF-3 cellular DNA either replicate more
slowly than do other BaEV proviruses or that most of these ge-
nomes are not infectious.
Thus, the proviruses that transfection and infection experi-
ments detected are those that replicate best (even though others
may also replicate, as shown for clone 14A2). Also, the absence
of infectious genomes of a particular class [e.g., those lacking
BamHI site (AB*)] does not necessarily mean that the feature
is lethal but just that it is not present in the infectious genomes
that we detected.
The above results show that the nondefective proviruses of
BEF-3 cells may or may not contain BamHI site (BC) which is
located near the 5' end of the pol gene; however, a Xho I site
near the 3' end of the pol gene ofone nondefective BaEV clone
(14A2) is not present in the other nondefective BaEV genomes
that we detected.
Note Added in Proof. It might be suggested that the failure of DNA
from dog cells transfected with BEF-3 DNA to be cleaved internally
by Xho I (Fig. 5, lane B) is because this site is methylated in dog cells.
However, we have now found that the proviruses resulting from trans-
fection of clone 14A2 into dog cells are largely cut at this position by
Xho I. Therefore, methylation of the site does not explain the failure
of BEF-3 transfected dog DNA to be cleaved there.
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